T1	CHEM 13 24	lansoprazol
#1	AnnotatorNotes T1	C0050940; lansoprazole; Organic Chemical · Pharmacologic Substance
T2	PROC 45 56	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 531 535	ERNE
#3	AnnotatorNotes T3	C2242528; Non-erosive reflux disease; Disease or Syndrome
T4	DISO 63 101	enfermedad por reflujo gastroesofágico
#4	AnnotatorNotes T4	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T5	DISO 131 164	infección por Helicobacter pylori
#5	AnnotatorNotes T5	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T6	DISO 277 295	esofagítis péptica
#6	AnnotatorNotes T6	C0014869; Peptic Esophagitis; Disease or Syndrome
T7	CHEM 184 219	inhibidores de la bomba de protones
#7	AnnotatorNotes T7	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T8	CHEM 221 224	IBP
#8	AnnotatorNotes T8	C0358591; Proton Pump Inhibitors; Pharmacologic Substance
T9	CHEM 234 242	fármacos
#9	AnnotatorNotes T9	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T10	PROC 304 327	control de los síntomas
#10	AnnotatorNotes T10	C1274136; Symptom control (regime/therapy); Therapeutic or Preventive Procedure
T11	PROC 2170 2205	biopsias de cuerpo y antro gástrico
T12	DISO 334 372	enfermedad por reflujo gastroesofágico
#11	AnnotatorNotes T12	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T13	DISO 374 378	ERGE
#12	AnnotatorNotes T13	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T14	DISO 416 420	ERGE
#13	AnnotatorNotes T14	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T15	DISO 435 445	esofagitis
#14	AnnotatorNotes T15	C0014868; Esophagitis; Disease or Syndrome
T16	PROC 461 471	endoscopia
#15	AnnotatorNotes T16	C0014245; Endoscopy (procedure); Diagnostic Procedure
T17	DISO 488 492	ERGE
#16	AnnotatorNotes T17	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T18	PROC 497 507	endoscopia
#17	AnnotatorNotes T18	C0014245; Endoscopy (procedure); Diagnostic Procedure
T19	DISO 558 577	infección H. pylori
#18	AnnotatorNotes T19	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T20	DISO 600 604	ERGE
#19	AnnotatorNotes T20	C0017168; Gastroesophageal reflux disease; Disease or Syndrome
T21	PROC 730 744	ensayo clínico
#20	AnnotatorNotes T21	C0008976; Clinical Trials; Research Activity
T22	PROC 750 769	valorar la eficacia
#21	AnnotatorNotes T22	C1707887; Efficacy Study; Research Activity
T23	CHEM 773 784	lansoprazol
#22	AnnotatorNotes T23	C0050940; lansoprazole; Organic Chemical · Pharmacologic Substance
T24	PROC 801 832	control inicial de los síntomas
T25	DISO 839 843	ERNE
#23	AnnotatorNotes T25	C2242528; Non-erosive reflux disease; Disease or Syndrome
T26	DISO 893 912	infección H. pylori
#24	AnnotatorNotes T26	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T27	PROC 932 943	tratamiento
#25	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 981 1029	ensayo clínico piloto, unicéntrico, simple ciego
T29	DISO 319 327	síntomas
#26	AnnotatorNotes T29	C1457887; Symptoms; Sign or Symptom
T30	CHEM 1045 1068	medicación experimental
#27	AnnotatorNotes T30	C0304229; Experimental drug; Pharmacologic Substance
T31	DISO 1148 1171	infección por H. pylori
#28	AnnotatorNotes T31	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T32	DISO 1217 1221	ERNE
#29	AnnotatorNotes T32	C2242528; Non-erosive reflux disease; Disease or Syndrome
T33	DISO 1260 1267	pirosis
#30	AnnotatorNotes T33	C0018834; Heartburn; Sign or Symptom | C0043066; Waterbrash; Sign or Symptom
T34	DISO 3030 3044	sintomatología
#31	AnnotatorNotes T34	C3540840; Sign or Symptom; Finding
T35	PROC 1375 1384	protocolo
#32	AnnotatorNotes T35	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T36	PROC 1521 1530	protocolo
#33	AnnotatorNotes T36	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T37	PROC 1557 1568	tratamiento
#34	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	DISO 824 832	síntomas
#35	AnnotatorNotes T38	C1457887; Symptoms; Sign or Symptom
T39	CHEM 1611 1621	medicación
#36	AnnotatorNotes T39	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T40	CHEM 1647 1658	lansoprazol
#37	AnnotatorNotes T40	C0050940; lansoprazole; Organic Chemical · Pharmacologic Substance
T41	PROC 1692 1703	seguimiento
#38	AnnotatorNotes T41	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T42	DISO 1746 1753	pirosis
#39	AnnotatorNotes T42	C0018834; Heartburn; Sign or Symptom | C0043066; Waterbrash; Sign or Symptom
T43	PROC 1793 1804	tratamiento
#40	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	DISO 1908 1915	pirosis
#41	AnnotatorNotes T44	C0018834; Heartburn; Sign or Symptom | C0043066; Waterbrash; Sign or Symptom
T45	PROC 1957 1966	protocolo
#42	AnnotatorNotes T45	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T46	CHEM 2032 2042	medicación
#43	AnnotatorNotes T46	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T47	DISO 2093 2101	síntomas
#44	AnnotatorNotes T47	C1457887; Symptoms; Sign or Symptom
T48	DISO 2108 2118	enfermedad
#45	AnnotatorNotes T48	C0012634; Disease; Disease or Syndrome
T49	PROC 2133 2155	endoscopia diagnóstica
#46	AnnotatorNotes T49	C0014245; Endoscopy (procedure); Diagnostic Procedure + C0011900; Diagnosis; Diagnostic Procedure
T50	ANAT 2191 2205	antro gástrico
#47	AnnotatorNotes T50	C0034193; Pyloric antrum; Body Part, Organ, or Organ Component
T51	PROC 2232 2249	test de la ureasa
#48	AnnotatorNotes T51	C0585237; CLO test for helicobacter pylori; Laboratory Procedure
T52	DISO 2254 2277	infección por H. pylori
#49	AnnotatorNotes T52	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T53	PROC 2279 2316	Se valoró la eficacia del tratamiento
#50	AnnotatorNotes T53	C1707887; Efficacy Study; Research Activity
T54	PROC 2406 2420	test de ureasa
#51	AnnotatorNotes T54	C0585237; CLO test for helicobacter pylori; Laboratory Procedure (?)
T55	PROC 2483 2494	tratamiento
#52	AnnotatorNotes T55	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T56	DISO 2536 2550	sintomatología
#53	AnnotatorNotes T56	C3540840; Sign or Symptom; Finding
T57	DISO 2619 2626	pirosis
#54	AnnotatorNotes T57	C0018834; Heartburn; Sign or Symptom | C0043066; Waterbrash; Sign or Symptom
T58	DISO 2712 2735	infección por H. pylori
#55	AnnotatorNotes T58	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T59	PROC 2800 2811	tratamiento
#56	AnnotatorNotes T59	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T60	DISO 2839 2862	infección por H. pylori
#57	AnnotatorNotes T60	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T61	PROC 2914 2928	estudio piloto
#58	AnnotatorNotes T61	C0031928; Pilot Projects; Research Activity
T62	CHEM 2963 2974	lansoprazol
#59	AnnotatorNotes T62	C0050940; lansoprazole; Organic Chemical · Pharmacologic Substance
T63	PROC 2991 3002	tratamiento
#60	AnnotatorNotes T63	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T64	PROC 3016 3044	control de la sintomatología
#61	AnnotatorNotes T64	C1274136; Symptom control (regime/therapy); Therapeutic or Preventive Procedure
T65	DISO 3051 3055	ERNE
#62	AnnotatorNotes T65	C2242528; Non-erosive reflux disease; Disease or Syndrome
T66	PROC 3080 3102	estrategia terapéutica
T67	DISO 3148 3171	infección por H. pylori
#63	AnnotatorNotes T67	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T68	PROC 3225 3236	tratamiento
#64	AnnotatorNotes T68	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T69	ANAT 86 101	gastroesofágico
#65	AnnotatorNotes T69	C0744316; gastroesophageal; Body Location or Region
T70	ANAT 357 372	gastroesofágico
#66	AnnotatorNotes T70	C0744316; gastroesophageal; Body Location or Region
T71	ANAT 2182 2188	cuerpo
#67	AnnotatorNotes T71	C0227230; Body of stomach; Body Part, Organ, or Organ Component
T72	CHEM 2243 2249	ureasa
#68	AnnotatorNotes T72	C0041945; Urease; Amino Acid, Peptide, or Protein · Enzyme
T73	CHEM 2414 2420	ureasa
#69	AnnotatorNotes T73	C0041945; Urease; Amino Acid, Peptide, or Protein · Enzyme
T74	Dose 27 38	dosis bajas
#70	AnnotatorNotes T74	C0445550; Low dose; Quantitative Concept
T76	PHYS 262 270	curación
#71	AnnotatorNotes T76	C2004454; Recovery - healing process; Organism Function
T77	LIVB 402 411	pacientes
#72	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	Neg_cue 421 423	no
T81	LIVB 568 577	H. pylori
#73	AnnotatorNotes T81	C0079488; Helicobacter pylori; Bacterium
T84	Dose 785 790	15 mg
T85	Frequency 790 794	/día
T86	LIVB 903 912	H. pylori
#74	AnnotatorNotes T86	C0079488; Helicobacter pylori; Bacterium
T87	LIVB 946 955	Pacientes
#75	AnnotatorNotes T87	C0030705; Patients; Patient or Disabled Group
T89	LIVB 1090 1099	pacientes
#76	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	LIVB 1203 1212	pacientes
#77	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T91	Duration 1238 1255	al menos dos días
T92	Time 1268 1274	diurna
#78	AnnotatorNotes T92	C0332169; Daytime; Temporal Concept
T93	Time 1277 1285	nocturna
#79	AnnotatorNotes T93	C0240526; Night time; Temporal Concept
T94	Duration 1301 1324	las dos últimas semanas
T95	Neg_cue 1326 1339	Se excluyeron
T96	LIVB 1342 1351	pacientes
#80	AnnotatorNotes T96	C0030705; Patients; Patient or Disabled Group
T97	LIVB 1405 1414	pacientes
#81	AnnotatorNotes T97	C0030705; Patients; Patient or Disabled Group
T98	LIVB 1429 1436	mujeres
#82	AnnotatorNotes T98	C0043210; Woman; Population Group
T99	LIVB 1442 1449	hombres
#83	AnnotatorNotes T99	C0025266; Male population group; Population Group
T100	Age 1469 1476	49 años
T101	LIVB 1536 1545	pacientes
#84	AnnotatorNotes T101	C0030705; Patients; Patient or Disabled Group
T102	Duration 1577 1588	dos semanas
T103	Dose 1593 1604	una cápsula
T104	Dose 1634 1639	15 mg
T105	Frequency 1639 1643	/día
T106	Frequency 1704 1710	diario
T107	Time 1754 1760	diurna
#85	AnnotatorNotes T107	C0332169; Daytime; Temporal Concept
T108	Time 1763 1771	nocturna
#86	AnnotatorNotes T108	C0240526; Night time; Temporal Concept
T109	LIVB 1845 1854	pacientes
#87	AnnotatorNotes T109	C0030705; Patients; Patient or Disabled Group
T111	LIVB 2339 2348	pacientes
#88	AnnotatorNotes T111	C0030705; Patients; Patient or Disabled Group
T112	LIVB 2449 2458	pacientes
#89	AnnotatorNotes T112	C0030705; Patients; Patient or Disabled Group
T113	LIVB 2556 2565	pacientes
#90	AnnotatorNotes T113	C0030705; Patients; Patient or Disabled Group
T114	Date 2649 2665	la última semana
T115	LIVB 2682 2691	pacientes
#91	AnnotatorNotes T115	C0030705; Patients; Patient or Disabled Group
T117	LIVB 2819 2828	pacientes
#92	AnnotatorNotes T117	C0030705; Patients; Patient or Disabled Group
T118	Neg_cue 2835 2838	sin
T119	Dose 2975 2980	15 mg
T120	Frequency 2980 2984	/día
T121	Spec_cue 3057 3065	pudiendo
T123	LIVB 145 164	Helicobacter pylori
#93	AnnotatorNotes T123	C0079488; Helicobacter pylori; Bacterium
T125	LIVB 1162 1171	H. pylori
#94	AnnotatorNotes T125	C0079488; Helicobacter pylori; Bacterium
T126	LIVB 1495 1504	población
#95	AnnotatorNotes T126	C1257890; Population; Population Group
T127	Form 1597 1604	cápsula
#96	AnnotatorNotes T127	C4722245; Capsule Dose Form Category; Biomedical or Dental Material
T128	LIVB 2268 2277	H. pylori
#97	AnnotatorNotes T128	C0079488; Helicobacter pylori; Bacterium
T129	LIVB 2726 2735	H. pylori
#98	AnnotatorNotes T129	C0079488; Helicobacter pylori; Bacterium
T130	LIVB 2853 2862	H. pylori
#99	AnnotatorNotes T130	C0079488; Helicobacter pylori; Bacterium
T131	LIVB 3162 3171	H. pylori
#100	AnnotatorNotes T131	C0079488; Helicobacter pylori; Bacterium
T75	PROC 1103 1114	doble ciego
#101	AnnotatorNotes T75	C0013072; Double-Blind Method; Research Activity
T79	LIVB 2351 2371	médicos responsables
#102	AnnotatorNotes T79	C4708568; Medically responsible investigator; Professional or Occupational Group
T80	Spec_cue 2948 2956	orientan
A1	Assertion T15 Negated
A2	Assertion T96 Negated
A3	Assertion T66 Speculated
A4	Assertion T60 Negated
A7	Assertion T64 Speculated
R1	Negation Arg1:T118 Arg2:T60	
T82	Neg_cue 2317 2320	sin
T83	CONC 2321 2330	conocerse
A5	Assertion T83 Negated
R2	Negation Arg1:T82 Arg2:T83	
T88	Neg_cue 2737 2739	No
T110	CONC 2754 2765	diferencias
A6	Assertion T110 Negated
#103	AnnotatorNotes T110	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T88 Arg2:T110	
R4	Negation Arg1:T78 Arg2:T15	
T116	Neg_cue 519 521	no
T122	Quantifier_or_Qualifier 522 529	erosiva
A8	Assertion T122 Negated
#104	AnnotatorNotes T122	C0439679; Erosive; Qualitative Concept
R5	Negation Arg1:T116 Arg2:T122	
R6	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T122	
T124	Quantifier_or_Qualifier 105 112	erosiva
A9	Assertion T124 Negated
#105	AnnotatorNotes T124	C0439679; Erosive; Qualitative Concept
T132	Neg_cue 102 104	no
R7	Negation Arg1:T132 Arg2:T124	
R8	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T124	
T133	Quantifier_or_Qualifier 1073 1081	conocida
A10	Assertion T133 Negated
#106	AnnotatorNotes T133	C0205309; Known; Qualitative Concept
T134	Neg_cue 1070 1072	no
R9	Negation Arg1:T134 Arg2:T133	
T135	Neg_cue 3172 3174	no
T136	CONC 3175 3182	influye
A11	Assertion T136 Negated
#107	AnnotatorNotes T136	C4054723; Influence; Conceptual Entity
R10	Negation Arg1:T135 Arg2:T136	
T137	Quantifier_or_Qualifier 3074 3079	buena
A12	Assertion T137 Speculated
R11	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T137	
T138	Quantifier_or_Qualifier 3103 3110	inicial
A13	Assertion T138 Speculated
R12	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T138	
#108	AnnotatorNotes T83	C0205309; Known; Qualitative Concept
R13	Speculation Arg1:T80 Arg2:T64	
T139	Quantifier_or_Qualifier 3003 3009	eficaz
A14	Assertion T139 Speculated
#109	AnnotatorNotes T139	C1704419; Effective; Qualitative Concept
R14	Speculation Arg1:T80 Arg2:T139	
A15	Assertion T63 Speculated
R15	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T139	
R16	Speculation Arg1:T80 Arg2:T63	
R17	Speculation Arg1:T121 Arg2:T137	
R18	Speculation Arg1:T121 Arg2:T66	
R19	Speculation Arg1:T121 Arg2:T138	
T140	Observation 1356 1384	incumplimiento del protocolo
#110	AnnotatorNotes T140	C0184543; Noncompliance with therapeutic regimen; Finding (?)
R20	Location_of Arg1:T69 Arg2:T4	
R21	Has_Dose_or_Strength Arg1:T1 Arg2:T74	
R22	Used_for Arg1:T1 Arg2:T2	
R23	Causes Arg1:T123 Arg2:T5	
R24	Overlap Arg1:T4 Arg2:T5	
T141	Quantifier_or_Qualifier 247 255	eficaces
#111	AnnotatorNotes T141	C1704419; Effective; Qualitative Concept
R25	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T141	
R26	Causes Arg1:T8 Arg2:T76	
R27	Causes Arg1:T7 Arg2:T76	
R28	Before Arg1:T6 Arg2:T76	
R30	Location_of Arg1:T70 Arg2:T12	
R31	Location_of Arg1:T70 Arg2:T13	
R32	Causes Arg1:T12 Arg2:T29	
R34	Before Arg1:T10 Arg2:T76	
R33	Experiences Arg1:T77 Arg2:T14	
R35	Experiences Arg1:T77 Arg2:T15	
R36	Experiences Arg1:T77 Arg2:T16	
R37	Experiences Arg1:T77 Arg2:T17	
R38	Experiences Arg1:T77 Arg2:T18	
T142	Result_or_Value 508 516	negativa
#112	AnnotatorNotes T142	C0205160; Negative; Finding
R39	Has_Result_or_Value Arg1:T18 Arg2:T142	
R40	Experiences Arg1:T77 Arg2:T3	
R41	Causes Arg1:T81 Arg2:T19	
R42	Causes Arg1:T86 Arg2:T26	
R43	Causes Arg1:T128 Arg2:T52	
R44	Causes Arg1:T130 Arg2:T60	
R45	Causes Arg1:T131 Arg2:T67	
R47	Overlap Arg1:T19 Arg2:T20	
R48	Has_Dose_or_Strength Arg1:T23 Arg2:T84	
R49	Has_Frequency Arg1:T23 Arg2:T85	
R51	Causes Arg1:T25 Arg2:T38	
R52	Overlap Arg1:T25 Arg2:T26	
R53	Overlap Arg1:T38 Arg2:T26	
T143	Observation 919 943	respuesta al tratamiento
#113	AnnotatorNotes T143	C1319171; Medication response; Finding
R54	Overlap Arg1:T23 Arg2:T143	
R55	Used_for Arg1:T23 Arg2:T27	
R58	Experiences Arg1:T87 Arg2:T30	
R59	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T133	
R60	Experiences Arg1:T89 Arg2:T30	
R61	Causes Arg1:T125 Arg2:T31	
R62	Experiences Arg1:T89 Arg2:T31	
R63	Experiences Arg1:T87 Arg2:T31	
R64	Experiences Arg1:T90 Arg2:T32	
R65	Has_Duration_or_Interval Arg1:T33 Arg2:T91	
R66	Overlap Arg1:T33 Arg2:T92	
R67	Overlap Arg1:T33 Arg2:T93	
R68	Overlap Arg1:T32 Arg2:T33	
R69	Overlap Arg1:T33 Arg2:T94	
R70	Negation Arg1:T95 Arg2:T96	
R73	Has_Age Arg1:T97 Arg2:T100	
R74	Has_Age Arg1:T126 Arg2:T100	
R75	Has_Age Arg1:T99 Arg2:T100	
R76	Has_Age Arg1:T98 Arg2:T100	
R77	Experiences Arg1:T101 Arg2:T37	
R78	Has_Duration_or_Interval Arg1:T39 Arg2:T102	
R79	Has_Drug_Form Arg1:T39 Arg2:T127	
R80	Has_Dose_or_Strength Arg1:T39 Arg2:T103	
R81	Used_for Arg1:T39 Arg2:T37	
R82	Has_Frequency Arg1:T40 Arg2:T105	
R83	Has_Dose_or_Strength Arg1:T40 Arg2:T104	
R84	Used_for Arg1:T40 Arg2:T37	
R86	Has_Frequency Arg1:T41 Arg2:T106	
R88	Overlap Arg1:T42 Arg2:T107	
R89	Overlap Arg1:T42 Arg2:T108	
R90	Experiences Arg1:T101 Arg2:T42	
R91	Experiences Arg1:T109 Arg2:T43	
T144	Quantifier_or_Qualifier 1886 1904	máximo un episodio
R92	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T144	
T145	Quantifier_or_Qualifier 1919 1934	intensidad leve
R93	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T145	
R94	Causes Arg1:T48 Arg2:T47	
T146	Observation 2057 2101	controla de forma satisfactoria los síntomas
#114	AnnotatorNotes T146	C5547101; Managing to control symptoms; Finding (?)
R95	Causes Arg1:T46 Arg2:T146	
R96	Experiences Arg1:T109 Arg2:T44	
R97	Experiences Arg1:T109 Arg2:T46	
R98	Experiences Arg1:T109 Arg2:T47	
R99	Experiences Arg1:T109 Arg2:T48	
R100	Experiences Arg1:T109 Arg2:T146	
R102	Location_of Arg1:T71 Arg2:T11	
R103	Location_of Arg1:T50 Arg2:T11	
R104	Before Arg1:T11 Arg2:T51	
R105	Overlap Arg1:T49 Arg2:T11	
R108	Experiences Arg1:T111 Arg2:T54	
R109	Before Arg1:T54 Arg2:T53	
R110	Experiences Arg1:T112 Arg2:T55	
T147	Observation 2499 2550	controlaba de forma satisfactoria la sintomatología
#115	AnnotatorNotes T147	C5547101; Managing to control symptoms; Finding (?)
R111	Experiences Arg1:T112 Arg2:T147	
R112	Causes Arg1:T55 Arg2:T147	
R113	Experiences Arg1:T112 Arg2:T56	
T148	Quantifier_or_Qualifier 2597 2615	máximo un episodio
R116	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T148	
T149	Quantifier_or_Qualifier 2630 2645	intensidad leve
R117	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T149	
R118	Experiences Arg1:T113 Arg2:T57	
R119	Overlap Arg1:T57 Arg2:T114	
R114	Experiences Arg1:T113 Arg2:T55	
R115	Experiences Arg1:T115 Arg2:T58	
R120	Causes Arg1:T129 Arg2:T58	
T150	Observation 2787 2811	respuesta al tratamiento
#116	AnnotatorNotes T150	C4055223; Clinical Response; Finding (?)
R121	Experiences Arg1:T117 Arg2:T59	
R122	Experiences Arg1:T117 Arg2:T150	
R123	Overlap Arg1:T150 Arg2:T59	
R124	Overlap Arg1:T143 Arg2:T27	
R125	Experiences Arg1:T117 Arg2:T60	
R127	Used_for Arg1:T62 Arg2:T63	
R128	Has_Dose_or_Strength Arg1:T62 Arg2:T119	
R129	Has_Frequency Arg1:T62 Arg2:T120	
R130	Before Arg1:T63 Arg2:T64	
R131	Causes Arg1:T65 Arg2:T34	
R133	Before Arg1:T66 Arg2:T64	
R134	Overlap Arg1:T65 Arg2:T67	
R135	Used_for Arg1:T62 Arg2:T66	
T151	Observation 3212 3236	respuesta al tratamiento
#117	AnnotatorNotes T151	C4055223; Clinical Response; Finding (?)
R136	Overlap Arg1:T151 Arg2:T68	
R137	Used_for Arg1:T62 Arg2:T68	
T152	Quantifier_or_Qualifier 2766 2780	significativas
A16	Assertion T152 Negated
#118	AnnotatorNotes T152	C0750502; Significant; Idea or Concept
R126	Has_Quantifier_or_Qualifier Arg1:T110 Arg2:T152	
R139	Negation Arg1:T88 Arg2:T152	
T153	Quantifier_or_Qualifier 3183 3205	de forma significativa
A17	Assertion T153 Negated
#119	AnnotatorNotes T153	C0750502; Significant; Idea or Concept
R140	Has_Quantifier_or_Qualifier Arg1:T136 Arg2:T153	
R141	Negation Arg1:T135 Arg2:T153	
#120	AnnotatorNotes T145	C2945599; Mild (qualifier value); Qualitative Concept
#121	AnnotatorNotes T149	C2945599; Mild (qualifier value); Qualitative Concept
#122	AnnotatorNotes T137	C0205170; Good; Qualitative Concept
#123	AnnotatorNotes T138	C0205265; Initially; Temporal Concept
A18	Experiencer T77 Patient
A19	Experiencer T87 Patient
A20	Experiencer T89 Patient
A21	Experiencer T90 Patient
A22	Experiencer T96 Patient
A23	Experiencer T97 Patient
A24	Experiencer T98 Patient
A25	Experiencer T99 Patient
A26	Experiencer T126 Patient
A27	Experiencer T101 Patient
A28	Experiencer T109 Patient
A29	Experiencer T111 Patient
A30	Experiencer T79 Other
A31	Experiencer T112 Patient
A32	Experiencer T113 Patient
A33	Experiencer T115 Patient
A34	Experiencer T117 Patient
